Apr 16 |
Regeneron to 'vigorously defend' against DOJ on Eylea pricing complaint
|
Apr 15 |
UPDATE 1-Regeneron to defend against DOJ complaint on drug-price manipulation
|
Apr 15 |
Regeneron to defend against DOJ complaint on drug-price manipulation
|
Apr 15 |
Regeneron to defend US Justice Department's complaint on drug-pricing manipulation
|
Apr 15 |
Regeneron commits $500M to new venture capital fund
|
Apr 15 |
Antitrust fervor is gripping Washington and Silicon Valley. But lawsuits have been declining.
|
Apr 12 |
Regeneron (REGN) Accused of Fraudulent Practices Related to Eylea
|
Apr 12 |
Breaking Down Regeneron Pharmaceuticals: 13 Analysts Share Their Views
|
Apr 11 |
Stocks to Watch Thursday: Robinhood, Alpine Immune, Constellation Brands
|
Apr 11 |
Regeneron hits three-month low after DOJ complaint; RBC defends
|